Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
Yelda JozaghiMark E ZafereoMichelle D WilliamsMaria K Gule-MonroeJennifer Rui WangElizabeth G GrubbsAra VaporciyanMimi I HuNaifa BusaidyRamona DaduSteven G WaguespackVivek SubbiahMaria E CabanillasPublished in: Head & neck (2020)
This novel treatment strategy for locoregionally advanced RET-mutated MTC warrants further study in clinical trials.